UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047740
Receipt number R000054426
Scientific Title Investigation of QALY in patients with chronic renal failure undergoing different renal replacement therapies.
Date of disclosure of the study information 2022/09/30
Last modified on 2023/05/13 11:08:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examining Changes in Quality of Life Over Time in Patients with Chronic Kidney Disease

Acronym

Examining Changes in Quality of Life Over Time in Patients with Chronic Kidney Disease

Scientific Title

Investigation of QALY in patients with chronic renal failure undergoing different renal replacement therapies.

Scientific Title:Acronym

Investigation of QALY in patients with chronic renal failure undergoing different renal replacement therapies.

Region

Japan


Condition

Condition

Chronic kidney failure

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aim to investigate differences in QALYs between different renal replacement therapies.

Basic objectives2

Others

Basic objectives -Others

This study examine factors affect QALY.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Quality of Life
QALY

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are not receiving any concomitant therapy, whose condition is stable, and whose attending physician and the patient have agreed to participate.

Key exclusion criteria

No hospitalization during the first half year of the measurement, no acute illness currently under treatment, impaired cognitive function required for the measurement, and no consent for participation.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Yabe

Organization

Seirei Christopher University

Division name

Department of Physical therapy, School of Rehabilitation Sciences

Zip code

433-8558

Address

3453 Mikatahara, Kita-ku, Hamamatsu

TEL

0534391400

Email

yabe0909@gmail.com


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Yabe

Organization

Seirei Christopher University

Division name

Department of Physical therapy, School of Rehabilitation Sciences

Zip code

433-8558

Address

3453 Mikatahara, Kita-ku, Hamamatsu

TEL

0534391400

Homepage URL


Email

yabe0909@gmail.com


Sponsor or person

Institute

Seirei Christopher University

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Seirei Christopher University

Address

3453 Mikatahara, Kita-ku, Hamamatsu

Tel

0534391400

Email

hiroki-y@seirei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 12 Month 31 Day

Date of IRB

2022 Year 05 Month 18 Day

Anticipated trial start date

2022 Year 06 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Measuring changes in quality of life over time


Management information

Registered date

2022 Year 05 Month 12 Day

Last modified on

2023 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054426


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name